Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

Alkem Laboratories on Wednesday said it has launched a generic medication for the treatment of type-2 diabetes mellitus, ...

The researchers highlighted the importance of incorporating the Trabecular Bone Score alongside aBMD assessments for a more ...

The prevalence of LVH increased progressively across METS-VF quartiles, ranging from 7.9% to 31%. Higher METS-VF levels were ...

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...

Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) ...

Glenmark launches Empagliflozin and combinations in India under Glempa brand, aiming to improve glycemic control and reduce ...

The following is a summary of “Identification of Shared Pathways and Molecules Between Type 2 Diabetes and Lung ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...

Gestational diabetes risk factors are a family history of the condition, a higher BMI, a previous baby who was born at high ...

Glenmark Pharmaceuticals launches Empagliflozin, an SGLT2 inhibitor, in India under the brand name Glempa for glycemic ...